Success Metrics

Clinical Success Rate
80.0%

Based on 8 completed trials

Completion Rate
80%(8/10)
Active Trials
1(8%)
Results Posted
13%(1 trials)
Terminated
2(15%)

Phase Distribution

Ph not_applicable
10
77%
Ph phase_2
1
8%
Ph phase_3
2
15%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
1(7.7%)
Phase 3Large-scale testing
2(15.4%)
N/ANon-phased studies
10(76.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(8)
Terminated(2)
Other(2)

Detailed Status

Completed8
Terminated2
unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (7.7%)
Phase 32 (15.4%)
N/A10 (76.9%)

Trials by Status

recruiting18%
terminated215%
completed862%
unknown215%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials
NCT03941756Not Applicable

Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma

Recruiting
NCT03532581Not Applicable

Indocyanine Green Lymphangiography in Identifying Thoracic Duct During Neck Surgery

Completed
NCT00003654Not Applicable

Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer

Terminated
NCT00070317Not Applicable

Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer

Terminated
NCT00042926Not Applicable

Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer

Completed
NCT00003854Phase 3

Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer

Completed
NCT00012168Not Applicable

Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat

Completed
NCT02550951Not Applicable

Utility of MR Lymphangiography in Postoperative Follow-up of Lymphedema: Comparison With Lymphoscintigraphy

Unknown
NCT00004196Phase 3

Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis

Completed
NCT00005821Phase 2

Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer

Unknown
NCT00003186Not Applicable

Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer

Completed
NCT00438477Not Applicable

Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer

Completed
NCT00080860Not Applicable

Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer

Completed

All 13 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
13